迪馬股份(600565.SH):收到法院協助執行通知書
格隆匯 7 月 23日丨迪馬股份(600565.SH)公佈,公司於2020年7月22日收到重慶市第五中級人民法院(“重慶五中院”)的《協助執行通知書》【(2019)渝05執2676號】,要求公司協助執行。
依照《中華人民共和國民事訴訟法》的規定,重慶五中院要求提取被執行人重慶東銀控股集團有限公司、重慶碩潤石化有限責任公司、趙潔紅持有的公司全部股權所涉及的2019年現金紅利金額,並要求公司協助劃轉該部分金額至重慶五中院指定賬户。
公司將根據《協助執行通知書》的要求,協助重慶五中院進行提取及劃轉。上述協助執行不會對公司正常的經營發展造成不利影響,公司也按要求及時履行相應信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.